WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 662
GDP / capita (US$): 2'9981 Child (under 5 years) mortality rate: 812

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 873  860  847  834  822  723  590  359 
Births 24  24  24  24  24  22  23  14 
Surviving infants 23  23  22  22  22  20  21  13 
Pop. less than 5 years 109  108  106  104  103  99  108  68 
Pop. less than 15 years 294  290  287  285  284  299  265  167 
Female 15-49 years 233  231  228  224  220  174  134  80 

Number of reported case

(Click for retrospective incidence data for Djibouti)
Diphtheria 411 
Japanese encephalitis
Measles 28  709  49  48  183  104 
Mumps
Pertussis 48  25 
Polio*
Rubella 15 
Rubella (CRS) 16 
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Djibouti)
Vaccine year result method % card seen                                                
BCG 2009  71  PAPFAM   15  86  87  89  90  90  34  95 
DTP1 2009  68  PAPFAM   15  87  85  89  90  90  66 
DTP3 2009  43  PAPFAM   15  82  81  87  88  89  46  85 
HepB_BD          86  87 
HepB3 2009  43  PAPFAM   15  82  87  88  89 
Hib3 2009  43  PAPFAM   15  82  87  88  89 
JapEnc         
MCV 2009  57  PAPFAM   15  80  83  84  85  84  50  85 
MCV2          82 
PCV1          87 
PCV3          82 
Pol3 2009  43  PAPFAM   15  82  81  87  88  89  46  85 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  79  PAPFAM   15  65  70  69  70  15  80 
PAB         
VAD1          64  85  85  85  90 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Djibouti)
BCG 86  87  89  90  90  34  81 
DTP1 87  85  89  90  90  66  95 
DTP3 82  81  87  88  89  46  85 
HepB3 82  81  87  88  89 
HepB_BD 86  87 
Hib3 82  81  87  88  89 
MCV 80  83  84  85  84  50  85 
MCV2 82  82 
PAB 79  79  79  79  77  46  80 
PnC3 82 
Pol3 82  81  87  88  89  46  85 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 17
From 80 to 89% 33
From 50 to 79% 50
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 15 months; Yes
DTwPHibHepB 6, 10, 14 months; Yes
HepB birth; Yes
Measles 9, 15 months; Yes
OPV birth; 6, 10, 14 weeks; 15 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes From March 2014
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2010-2014  2010-2014  2008 - 2012  2008 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 50  33  83  67  67  67 
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100%      

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  Yes  Yes  Yes  Yes  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 26  No   

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.